Neoadjuvant Therapy for Stage II-IVA Resectable Esophageal Squamous Cell

Clinical trial NCT06006650 · RECRUITING

Trial details

NCT number: NCT06006650
Sponsor: Tang-Du Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Neoadjuvent PD-1 Inhibitor Chemotherapy Esophageal Squamous Cell Carcinoma

Start date: 2022-08-01
Primary completion: 2031-12-31
Enrollment: 114

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.